Quantitative and qualitative derangement of apolipoprotein B-containing lipoproteins as a risk factor for diabetic macroangiopathy in nonobese NIDDM subjects

被引:6
作者
Harano, Y
Kageyama, A
Nakao, Y
Hara, Y
Suzuki, M
Sato, A
Ikebuchi, M
Shinozaki, K
Tsushima, M
机构
关键词
D O I
10.2337/diab.45.3.S31
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cholesterol, triglylceride (TG), and apolipoprotein (ape) B were determined in plasma and in lipoprotein subfractions (VLDL, intermediate-density lipoproteins [IDL], LDL, and HDL) in nonobese NIDDM. subjects, who were classified into well-controlled, fairly controlled, or poorly controlled states with or without macrovascular complications (macroangiopathy [MA]). The same analyses were also performed on subjects who had coronary artery disease (CAD) with stable angina pectoris (SA) or unstable angina pectoris (UA) and acute myocardial infarction, cerebrovascular disease (CVD) with atherothrombotic or lacunar infarction, and arteriosclerosis obliterans (ASO). In nonobese NIDDM subjects, the number of apoB-containing lipoproteins (VLDL, IDL, and LDL) increased. This alteration was more prominent in subjects with poorly or fairly controlled disease as web as in subjects with IMA, but not in those with well-controlled NIDDM. Cholesterol/apoB in LDL decreased in subjects with poorly and fairly controlled diabetes or with MA and was correlated with low HDL cholesterol. The disorder is characterized by hyperbetalipoproteinemia with elevated LDL cholesterol and small dense LDL. In obese NIDDM subjects, the similar disorder was more pronounced. Glycemic control had less effect and hyperinsulinemia, if present, aggravated the lipid disorder. In those with CAD, the number of IDLs increased and the LDL fraction had the properties of small dense LDL. HDL cholesterol decreased. In those with UA, the LDL number increased without elevation of LDL cholesterol, indicating typical hyperbetalipoproteinemia. In subjects with atherothrombotic brain infarction, an increased number of small-sized LDLs was noted. In those with ASO, the number of VLDL and IDL increased with small LDL. HDL cholesterol decreased in those with CAD, cerebrovascular disease, and ASO. Since similar quantitative and qualitative alterations of apoB-containing lipoprotein have been observed in NIDDM patients as well as in those with macrovascular diseases, diabetic patients are thought to be more susceptible to the initiation and progression of atheromatous lesions in coronary, brain, and peripheral arteries.
引用
收藏
页码:S31 / S34
页数:4
相关论文
共 9 条
[1]   PERSISTENT ABNORMALITIES IN LIPOPROTEIN COMPOSITION IN NONINSULIN-DEPENDENT DIABETES AFTER INTENSIVE INSULIN THERAPY [J].
BAGDADE, JD ;
BUCHANAN, WE ;
KUUSI, T ;
TASKINEN, MR .
ARTERIOSCLEROSIS, 1990, 10 (02) :232-239
[2]   LIPOPROTEIN DISORDERS IN DIABETES-MELLITUS [J].
BROWN, WV .
MEDICAL CLINICS OF NORTH AMERICA, 1994, 78 (01) :143-161
[3]   ABNORMAL LIPOPROTEIN-LIPASE-MEDIATED PLASMA TRIGLYCERIDE REMOVAL IN UNTREATED DIABETES-MELLITUS ASSOCIATED WITH HYPERTRIGLYCERIDEMIA [J].
BRUNZELL, JD ;
PORTE, D ;
BIERMAN, EL .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (09) :901-907
[4]   HUMAN NONINSULIN-DEPENDENT DIABETES - IDENTIFICATION OF A DEFECT IN PLASMA-CHOLESTEROL TRANSPORT NORMALIZED INVIVO BY INSULIN AND INVITRO BY SELECTIVE IMMUNOADSORPTION OF APOLIPOPROTEIN-E [J].
FIELDING, CJ ;
REAVEN, GM ;
FIELDING, PE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (20) :6365-6369
[5]   HYPERLIPIDEMIA AND ATHEROSCLEROSIS IN EXPERIMENTAL INSULINOPENIC DIABETIC MONKEYS [J].
HARANO, Y ;
KOJIMA, H ;
KOSUGI, K ;
SUZUKI, M ;
HARADA, M ;
NAKANO, T ;
HIDAKA, H ;
KASHIWAGI, A ;
TORII, R ;
TANIGUCHI, Y ;
NISHIMORI, T ;
YASUDA, Y ;
SHIGETA, Y .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1992, 16 (03) :163-173
[6]  
HARANO Y, 1990, PROGR OBESITY RES, P299
[7]  
Hatch F T, 1968, Adv Lipid Res, V6, P1
[8]   ASSOCIATION OF HYPERAPOBETALIPOPROTEINEMIA WITH ENDOGENOUS HYPERTRIGLYCERIDEMIA AND ATHEROSCLEROSIS [J].
SNIDERMAN, AD ;
WOLFSON, C ;
TENG, B ;
FRANKLIN, FA ;
BACHORIK, PS ;
KWITEROVICH, PO .
ANNALS OF INTERNAL MEDICINE, 1982, 97 (06) :833-839
[9]   GLUCOSYLATION OF LOW-DENSITY LIPOPROTEINS TO AN EXTENT COMPARABLE TO THAT SEEN IN DIABETES SLOWS THEIR CATABOLISM [J].
STEINBRECHER, UP ;
WITZTUM, JL .
DIABETES, 1984, 33 (02) :130-134